The effect of WT1 expression on the prognosis of allogeneic hematopoietic stem cell transplantation in acute leukemia

被引:0
|
作者
蒋冰倩 [1 ]
机构
[1] Hematol & Bone Marrow Transplant Center,1st Affil Hosp,Med Sch,Zhejiang Univ
关键词
DFS; The effect of WT1 expression on the prognosis of allogeneic hematopoietic stem cell transplantation in acute leukemia; WT;
D O I
暂无
中图分类号
R733.71 [急性白血病];
学科分类号
100214 ;
摘要
Objective To study the effect of WT1 expression on the prognosis of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute leukemia (AL) and its significance as molecular marker to dynamically monitor minimal residual disease (MRD). Methods Retrospectively analyzed those AL patients who underwent
引用
收藏
页码:56 / 57
页数:2
相关论文
共 50 条
  • [21] The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia
    Ogawa, H
    Tamaki, H
    Ikegame, K
    Soma, T
    Kawakami, M
    Tsuboi, A
    Kim, EH
    Hosen, N
    Murakami, M
    Fujioka, T
    Masuda, T
    Taniguchi, Y
    Nishida, S
    Oji, Y
    Oka, Y
    Sugiyama, H
    BLOOD, 2003, 101 (05) : 1698 - 1704
  • [22] Relapse of acute myeloid leukemia after allogeneic stem cell transplantation is associated with gain of WT1 alterations and high mutation load
    Vosberg, Sebastian
    Hartmann, Luise
    Metzeler, Klaus H.
    Konstandin, Nikola P.
    Schneider, Stephanie
    Varadharajan, Ashok
    Hauser, Andreas
    Krebs, Stefan
    Blum, Helmut
    Bohlander, Stefan K.
    Hiddemann, Wolfgang
    Tischer, Johanna
    Spiekermann, Karsten
    Greif, Philipp A.
    HAEMATOLOGICA, 2018, 103 (12) : E581 - E584
  • [23] Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia
    Candoni, Anna
    Tiribelli, Mario
    Toffoletti, Eleonora
    Cilloni, Daniela
    Chiarvesio, Alexia
    Michelutti, Angela
    Simeone, Erica
    Pipan, Corrado
    Saglio, Giuseppe
    Fanin, Renato
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (01) : 61 - 68
  • [24] Detection of relapse after hematopoietic stem cell transplantation in childhood by monitoring of WT1 expression and chimerism
    Caroline Woehlecke
    Susan Wittig
    Juliane Sanft
    Hermann Kreyenberg
    Bernd Gruhn
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 1283 - 1290
  • [25] MONITORING OF MINIMAL RESIDUAL DISEASE BY QUANTITATIVE WT1 GENE EXPRESSION FOLLOWING REDUCE INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA
    Candoni, A.
    Toffoletti, E.
    Gallina, R.
    Simeone, E.
    Chiozzotto, M.
    Volpetti, S.
    Fanin, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 212 - 212
  • [26] Monitoring of minimal residual disease by quantitative WT1 gene expression following reduced intensity conditioning allogeneic stem cell transplantation in acute myeloid leukemia
    Candoni, Anna
    Toffoletti, Eleonora
    Gallina, Roberto
    Simeone, Erica
    Chiozzotto, Marianna
    Volpetti, Stefano
    Fanin, Renato
    CLINICAL TRANSPLANTATION, 2011, 25 (02) : 308 - 316
  • [27] Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant
    Siba El Hussein
    Courtney D. DiNardo
    Koichi Takahashi
    Joseph D. Khoury
    Hong Fang
    Ken Furudate
    Kirill A. Lyapichev
    Sofia Garces
    Rashmi Kanagal-Shamanna
    Chi Young Ok
    Keyur P. Patel
    Mark J. Routbort
    Farhad Ravandi
    L. Jeffrey Medeiros
    Sa A. Wang
    Sanam Loghavi
    Bone Marrow Transplantation, 2022, 57 : 370 - 376
  • [28] WT1 and TP53 as valuable diagnostic biomarkers for relapse after hematopoietic stem cell transplantation in acute myeloid leukemia
    Asghari-Ghomi, Ali
    Fallahian, Faranak
    Garavand, Javad
    Mohammadi, Mohammad Hossein
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [29] Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant
    El Hussein, Siba
    DiNardo, Courtney D.
    Takahashi, Koichi
    Khoury, Joseph D.
    Fang, Hong
    Furudate, Ken
    Lyapichev, Kirill A.
    Garces, Sofia
    Kanagal-Shamanna, Rashmi
    Ok, Chi Young
    Patel, Keyur P.
    Routbort, Mark J.
    Ravandi, Farhad
    Medeiros, L. Jeffrey
    Wang, Sa A.
    Loghavi, Sanam
    BONE MARROW TRANSPLANTATION, 2022, 57 (03) : 370 - 376
  • [30] WT1 Measurable Residual Disease Assay in Patients With Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation: Optimal Time Points, Thresholds, and Candidates
    Cho, Byung-Sik
    Min, Gi-June
    Park, Sung-Su
    Shin, Seung-Hwan
    Yahng, Seung-Ah
    Jeon, Young-Woo
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Kim, Dong-Wook
    Lee, Jong-Wook
    Kim, Myungsin
    Kim, Younggu
    Kim, Hee-Je
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (10) : 1925 - 1932